CASILI, Giovanna
 Distribuzione geografica
Continente #
NA - Nord America 1.397
EU - Europa 1.346
AS - Asia 226
AF - Africa 2
SA - Sud America 2
OC - Oceania 1
Totale 2.974
Nazione #
US - Stati Uniti d'America 1.397
IE - Irlanda 510
SE - Svezia 328
IT - Italia 243
CN - Cina 166
PL - Polonia 162
IN - India 42
UA - Ucraina 28
BE - Belgio 21
FI - Finlandia 15
VN - Vietnam 10
AT - Austria 9
GB - Regno Unito 7
NL - Olanda 6
DE - Germania 5
FR - Francia 5
JP - Giappone 4
CH - Svizzera 2
CL - Cile 2
HK - Hong Kong 2
RU - Federazione Russa 2
SC - Seychelles 2
AU - Australia 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
ES - Italia 1
PH - Filippine 1
SG - Singapore 1
Totale 2.974
Città #
Dublin 510
Chandler 411
Nyköping 280
Warsaw 162
Ashburn 153
Messina 82
Princeton 76
Ann Arbor 58
Medford 54
New York 54
Beijing 52
Des Moines 32
Jacksonville 27
Dearborn 26
Pune 25
Brussels 20
Wilmington 20
Piazza Armerina 17
Catania 16
Nanjing 13
Cambridge 12
Hyderabad 12
Jinan 12
Marsala 12
Washington 12
Dong Ket 10
Boardman 9
Guangzhou 9
Helsinki 9
Vienna 9
Zhengzhou 9
Catanzaro 8
Hangzhou 8
Shenyang 8
Tappahannock 8
Francofonte 7
Haikou 6
Hebei 6
Lanzhou 6
San Mateo 6
Taizhou 6
Fuzhou 5
Houston 5
Redwood City 5
Rome 5
Seattle 5
Bremen 4
Cagliari 4
Los Angeles 4
Milan 4
Nanchang 4
Santa Maria del Cedro 4
Corigliano Calabro 3
Lago 3
Norwalk 3
Tianjin 3
Wakayama 3
Brembate di Sopra 2
Caltanissetta 2
Changsha 2
Fairfield 2
Florence 2
Fort Worth 2
Hong Kong 2
Jiaxing 2
Lappeenranta 2
London 2
Mumbai 2
Naaldwijk 2
Ningbo 2
Orbassano 2
Pavia 2
Philadelphia 2
Ragusa 2
Riva 2
Rozendaal 2
Solarino 2
Austin 1
Biancavilla 1
Bitonto 1
Brooklyn 1
Ceska 1
Chicago 1
Dalian 1
Davao City 1
Falls Church 1
Fiorano Modenese 1
Fremont 1
Gatchina 1
Irving 1
Kampenhout 1
Kyiv 1
Lancaster 1
Madrid 1
Napoli 1
Nashville 1
Pedara 1
Qingdao 1
Singapore 1
Spezzano Della Sila 1
Totale 2.399
Nome #
The in vivo pharmacological manipulation of the Nrf-2 pathway and its therapeutic significance in brain diseases, with a possible implication in H2S-regulated lipidic metabolism 100
The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2 93
B-Cell Depletion with CD20 Antibodies as New Approach in the Treatment of Inflammatory and Immunological Events Associated with Spinal Cord Injury 83
Dimethyl fumarate reduces inflammatory responses in experimental colitis 81
Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of acute and chronic inflammation 76
Multiple mechanisms of dimethyl fumarate in amyloid β-induced neurotoxicity in human neuronal cells 75
Dimethyl fumarate attenuates neuroinflammation and neurobehavioral deficits induced by experimental traumatic brain injury 74
N-palmitoylethanolamide Prevents Parkinsonian Phenotypes in Aged Mice 65
Protective effects of xyloglucan in association with the polysaccharide gelose in an experimental model of gastroenteritis and urinary tract infections 64
Fumaric acid esters attenuate degeneration and promote functional recovery following Parkinson’s disease 64
The anti-inflammatory and antioxidant effects of sodium propionate 64
TLR-4/Wnt modulation as new therapeutic strategy in the treatment of glioblastomas 62
Fumaric Acid Esters Attenuate Secondary Degeneration and Promote Functional Recovery Following Experimental Spinal Cord Injury 59
Dimethyl fumarate alleviates the nitroglycerin (NTG)-induced migraine in mice 54
Autophagy and Liver Diseases 53
Effect of a Product Containing Xyloglucan and Pea Protein on a Murine Model of Atopic Dermatitis 53
TAK1 inhibitor enhances the therapeutic treatment for glioblastoma 53
Effect of ultra-micronized-palmitoylethanolamide and acetyl-l-carnitine on experimental model of inflammatory pain 53
Evaluation of a Product Containing Xyloglucan and Pea Protein on Skin Barrier Permeability 52
B Cell depletion with CD20 antibodies as new approach in the treatment of inflammatory and immunological events associated with spinal cord 51
Efficacy of Xyloglucan against Escherichia coli Extraintestinal Urinary Tract Infection: An in vivo Study 51
Modulation of NLRP3 inflammasome attenuated inflammatory response associated to diarrhea-predominant irritable bowel syndrome 49
Co-ultra PEALut enhances endogenous repair response following moderate traumatic brain injury 48
Towards new therapies for glioblastoma treatment: role of Dkk-3 and Claudin-5. 47
null 47
The inhibition of prolyl oligopeptidase as new target to counteract chronic venous insufficiency: Findings in a mouse model 44
KYP-2047, an inhibitor of prolyl-oligopeptidase, reduces glioblastoma proliferation through angiogenesis and apoptosis modulation 44
Micronized palmitoylethanolamide (PEA-m): a new pharmacological strategy to prevent neurodegenerative disease associated to the old age 43
Therapeutic potential of flavonoids in the treatment of chronic venous insufficiency 43
Traumatic Brain Injury Leads to Development of Parkinson's Disease in Mice 42
Towards new therapies for glioblastoma treatment: role of Dkk-3 and Claudin-5 40
Beneficial effect of KYP-2047, a propyl-oligopeptidase inhibitor, on oral squamous cell carcinoma 40
Poly (Adp-ribose) polymerase inhibitor, abt888, improved cisplatin effect in human oral cell carcinoma 39
The protective role of prolyl oligopeptidase (pop) inhibition in acute lung injury induced by intestinal ischemia-reperfusion 38
Effect of pea protein plus grape seed dry extract on a murine model of Candida albicans induced vaginitis 37
Topical delivery of curcumin by choline-calix[4]arene-based nanohydrogel improves its therapeutic effect on a psoriasis mouse model 37
Role of ABT888, a Novel Poly(ADP-Ribose) Polymerase (PARP) Inhibitor in Countering Autophagy and Apoptotic Processes Associated to Spinal Cord Injury 37
Magnesium prevents both H2O2- and NEM-induced oxidative damage at Band 3 protein level in human erythrocytes. 36
Synergic therapeutic potential of PEA-Um treatment and NAAA enzyme silencing in the management of neuroinflammation 36
Inhibition of Prolyl Oligopeptidase Prevents Consequences of Reperfusion following Intestinal Ischemia 36
Efficacy of a Product Containing Xyloglucan and Pea Protein on Intestinal Barrier Function in a Partial Restraint Stress Animal Model 36
Protective effect of sodium propionate in Aβ1-42 -induced neurotoxicity and spinal cord trauma 34
Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis 34
NLRP3 Inflammasome Inhibitor BAY-117082 Reduces Oral Squamous Cell Carcinoma Progression 34
Role of calixarene in chemotherapy delivery strategies 34
The inhibition of mammalian target of rapamycin (mTOR) in improving inflammatory response after traumatic brain injury 33
Evaluating the Protective Properties of a Xyloglucan-Based Nasal Spray in a Mouse Model of Allergic Rhinitis 33
Properties of a new food supplement containing Actinia equina extract 32
The protective role of prolyl oligopeptidase (Pop) inhibition in kidney injury induced by renal ischemia–reperfusion 32
Dimethyl Fumarate (DMF) Alleviated Post-Operative (PO) Pain through the N-Methyl-d-Aspartate (NMDA) Receptors 29
Sodium Butyrate Exerts Neuroprotective Effects in Spinal Cord Injury 29
TBK1 Inhibitor Exerts Antiproliferative Effect on Glioblastoma Multiforme Cells 29
Immunomodulatory effect of microglia-released cytokines in gliomas 27
Adenosine Targeting as a New Strategy to Decrease Glioblastoma Aggressiveness 24
null 24
Modulation of Dkk-3 and claudin-5 as new therapeutic strategy in the treatment of meningiomas 24
SCFA Treatment Alleviates Pathological Signs of Migraine and Related Intestinal Alterations in a Mouse Model of NTG-Induced Migraine 24
Potential Therapeutic Effects of PPAR Ligands in Glioblastoma 24
Ulva pertusa, a Marine Green Alga, Attenuates DNBS-Induced Colitis Damage via NF-κB/Nrf2/SIRT1 Signaling Pathways 23
Pea-oxa mitigates oxaliplatin-induced painful neuropathy through nf-κb/nrf-2 axis 23
GSK343, an Inhibitor of Enhancer of Zeste Homolog 2, Reduces Glioblastoma Progression through Inflammatory Process Modulation: Focus on Canonical and Non-Canonical NF-κB/IκBα Pathways 23
null 23
FeTPPS reduces secondary damage and improves neurobehavioral functions after traumatic brain injury 22
A New Approach for the Treatment of Recurrent Vulvovaginal Candidiasis with a Combination of Pea Protein, Grape Seed Extract, and Lactic Acid Assessed In Vivo 21
Protein Kinase Inhibitors as a New Target for Immune System Modulation and Brain Cancer Management 21
SUN11602, a bFGF mimetic, modulated neuroinflammation, apoptosis and calcium-binding proteins in an in vivo model of MPTP-induced nigrostriatal degeneration 20
A Combination of Xyloglucan, Pea Protein and Chia Seed Ameliorates Intestinal Barrier Integrity and Mucosa Functionality in a Rat Model of Constipation-Predominant Irritable Bowel Syndrome 20
BAY-117082-driven NLRP3 inflammasome inhibition resolves nitro-glycerine (NTG) neuronal damage in in vivo model of migraine 20
The Pivotal Role of Protein Phosphatase 2A (PP2A) in Brain Tumors 19
null 19
Supplementation with SCFAs Re-Establishes Microbiota Composition and Attenuates Hyperalgesia and Pain in a Mouse Model of NTG-Induced Migraine 18
Sodium Propionate Contributes to Tumor Cell Growth Inhibition through PPAR-γ Signaling 17
Treatment with luteolin improves lipopolysaccharide‐induced periodontal diseases in rats 17
Therapeutic Potential of Dimethyl Fumarate in Counteract Oral Squamous Cell Carcinoma Progression by Modulating Apoptosis, Oxidative Stress and Epithelial–Mesenchymal Transition 16
Tlr7/8 in the pathogenesis of parkinson’s disease 15
null 15
Evaluation of the Efficacy of Xyloglucan, Pea Protein and Opuntia ficus-indica Extract in a Preclinical Model of Psoriasis 14
Efficacy of a Novel Therapeutic, Based on Natural Ingredients and Probiotics, in a Murine Model of Multiple Food Intolerance and Maldigestion 14
Selenium-Binding Protein 1 (SELENBP1) Supports Hydrogen Sulfide Biosynthesis and Adipogenesis 8
The Role of miR-128 in Neurodegenerative Diseases 7
The Transcription Factor Nrf2 Mediates the Effects of Antrodia camphorata Extract on Neuropathological Changes in a Mouse Model of Parkinson’s Disease 7
Efficacy of the Radical Scavenger, Tempol, to Reduce Inflammation and Oxidative Stress in a Murine Model of Atopic Dermatitis 7
Fumaric Acid Esters Attenuate Secondary Degeneration Following Spinal Cord Injury 7
Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC) 6
Effect of a combination of pea protein, grape seed extract and lactic acid in an in vivo model of bacterial vaginosis 6
Overview on Common Genes Involved in the Onset of Glioma and on the Role of Migraine as Risk Factor: Predictive Biomarkers or Therapeutic Targets? 5
Oxygen sensing in neurodegenerative diseases: current mechanisms, implication of transcriptional response and pharmacological modulation 5
Role of Basic Fibroblast Growth Factor in Cancer: Biological Activity, Targeted Therapies, and Prognostic Value 5
Prolyl oligopeptidase inhibition ameliorates experimental pulmonary fibrosis both in vivo and in vitro 4
Inhibition of LRRK2 Attenuates Depression-Related Symptoms in Mice with Moderate Traumatic Brain Injury 3
Neuroprotective effects of GSK-343 in an in vivo model of MPTP-induced nigrostriatal degeneration 3
An RNAi-Mediated Reduction in Transcription Factor Nrf-2 Blocks the Positive Effects of Dimethyl Fumarate on Metabolic Stress in Alzheimer's Disease 3
bFGF-like Activity Supported Tissue Regeneration, Modulated Neuroinflammation, and Rebalanced Ca2+ Homeostasis following Spinal Cord Injury 2
Corrigendum to “Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of acute and chronic inflammation” [Biochem. Pharmacol. 119 (2016) 27–41, (S0006295216302611), (10.1016/j.bcp.2016.09.001)] 1
DKK3 Expression in Glioblastoma: Correlations with Biomolecular Markers 1
Inhibition of the 3-mercaptopyruvate sulfurtransferase-hydrogen sulfide system promotes cellular lipid accumulation 1
Totale 3.160
Categoria #
all - tutte 14.681
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.681


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 1 0
2019/2020205 0 0 1 26 2 30 13 16 7 45 45 20
2020/2021459 22 27 86 28 60 15 46 68 60 24 10 13
2021/2022458 7 31 13 13 24 4 19 23 33 13 69 209
2022/20231.540 118 153 67 114 96 175 19 73 648 17 42 18
2023/2024436 23 70 28 48 38 172 8 21 1 20 7 0
Totale 3.160